278 related articles for article (PubMed ID: 30674321)
21. Fabry disease in cardiology practice: Literature review and expert point of view.
Hagège A; Réant P; Habib G; Damy T; Barone-Rochette G; Soulat G; Donal E; Germain DP
Arch Cardiovasc Dis; 2019 Apr; 112(4):278-287. PubMed ID: 30826269
[TBL] [Abstract][Full Text] [Related]
22. Fabry disease in patients with hypertrophic cardiomyopathy (HCM).
Beer G; Reinecke P; Gabbert HE; Hort W; Kuhn H
Z Kardiol; 2002 Dec; 91(12):992-1002. PubMed ID: 12490989
[TBL] [Abstract][Full Text] [Related]
23. Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy.
Yogasundaram H; Kim D; Oudit O; Thompson RB; Weidemann F; Oudit GY
Can J Cardiol; 2017 Jul; 33(7):883-897. PubMed ID: 28668140
[TBL] [Abstract][Full Text] [Related]
24. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
Vijapurapu R; Nordin S; Baig S; Liu B; Rosmini S; Augusto J; Tchan M; Hughes DA; Geberhiwot T; Moon JC; Steeds RP; Kozor R
Heart; 2019 Mar; 105(6):470-476. PubMed ID: 30282640
[TBL] [Abstract][Full Text] [Related]
25. Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study.
Graziani F; Laurito M; Pieroni M; Pennestrì F; Lanza GA; Coluccia V; Camporeale A; Pedicino D; Verrecchia E; Manna R; Crea F
J Am Soc Echocardiogr; 2017 Mar; 30(3):282-291. PubMed ID: 28069318
[TBL] [Abstract][Full Text] [Related]
26. Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease.
Krämer J; Niemann M; Störk S; Frantz S; Beer M; Ertl G; Wanner C; Weidemann F
Am J Cardiol; 2014 Sep; 114(6):895-900. PubMed ID: 25073565
[TBL] [Abstract][Full Text] [Related]
27. Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets.
Militaru S; Ginghina C; Popescu BA; Saftoiu A; Linhart A; Jurcut R
Eur Heart J Cardiovasc Imaging; 2018 Dec; 19(12):1313-1322. PubMed ID: 30247528
[TBL] [Abstract][Full Text] [Related]
28. Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
Vitale G; Ditaranto R; Graziani F; Tanini I; Camporeale A; Lillo R; Rubino M; Panaioli E; Di Nicola F; Ferrara V; Zanoni R; Caponetti AG; Pasquale F; Graziosi M; Berardini A; Ziacchi M; Biffi M; Santostefano M; Liguori R; Taglieri N; Nardi E; Linhart A; Olivotto I; Rapezzi C; Biagini E
Heart; 2022 Jan; 108(1):54-60. PubMed ID: 33563631
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease.
Hazari H; Belenkie I; Kryski A; White JA; Oudit GY; Thompson R; Fung T; Dehar N; Khan A
Can J Cardiol; 2018 Aug; 34(8):1041-1047. PubMed ID: 29935990
[TBL] [Abstract][Full Text] [Related]
30. Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy.
Karur GR; Robison S; Iwanochko RM; Morel CF; Crean AM; Thavendiranathan P; Nguyen ET; Mathur S; Wasim S; Hanneman K
Radiology; 2018 Aug; 288(2):398-406. PubMed ID: 29688154
[TBL] [Abstract][Full Text] [Related]
31. Cardiac Anderson-Fabry disease: lessons from a 25-year-follow up.
Brito D; Miltenberger-Miltenyi G; Moldovan O; Navarro C; Madeira HC
Rev Port Cardiol; 2014 Apr; 33(4):247.e1-7. PubMed ID: 24830310
[TBL] [Abstract][Full Text] [Related]
32. Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease.
Halfmann MC; Altmann S; Schoepf UJ; Reichardt C; Hennermann JB; Kreitner KF; Kloeckner R; Hahn F; Dueber C; Varga-Szemes A; Kampmann C; Emrich T
Eur Radiol; 2023 Mar; 33(3):2039-2051. PubMed ID: 36322192
[TBL] [Abstract][Full Text] [Related]
33. Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study.
Madsen CV; Bundgaard H; Rasmussen ÅK; Sørensen SS; Petersen JH; Køber L; Feldt-Rasmussen U; Petri H
Scand Cardiovasc J; 2017 Aug; 51(4):207-216. PubMed ID: 28545342
[TBL] [Abstract][Full Text] [Related]
34. Cardiac involvement in Anderson-Fabry disease.
Cauti FM; O'Mahony C; Pantazis A
BMJ Case Rep; 2010 Aug; 2010():. PubMed ID: 22767366
[TBL] [Abstract][Full Text] [Related]
35. The Fabry cardiomyopathy - diagnostic approach and current treatment.
Weidemann F; Ertl G; Wanner C; Krämer J
Curr Pharm Des; 2015; 21(4):473-8. PubMed ID: 25483948
[TBL] [Abstract][Full Text] [Related]
36. Cardiac involvement in Lysosomal Storage Diseases.
Sestito S; Parisi F; Tallarico V; Tarsitano F; Roppa K; Pensabene L; Chimenz R; Ceravolo G; Calabrò MP; De Sarro R; Moricca MT; Bonapace G; Concolino D
J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 2):107-119. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000609
[TBL] [Abstract][Full Text] [Related]
37. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
[TBL] [Abstract][Full Text] [Related]
38. Phenotype and genotype characterization and twin association in patients with Anderson-Fabry cardiomyopathy.
Gomez M; Molina L; Cladellas M; Ascoeta S; Soler C; Ble M; Ramirez A; Bruguera J
Cardiology; 2012; 121(2):71-5. PubMed ID: 22378313
[TBL] [Abstract][Full Text] [Related]
39. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
[TBL] [Abstract][Full Text] [Related]
40. Atypical patterns of cardiac involvement in Fabry disease.
Coughlan JJ; Elkholy K; O'Brien J; Kiernan T
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26989114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
